Review

November 7, 2024


Stem cell exosomes: new hope and future potential for relieving liver fibrosis
Lihua Li, Yongjie Liu, Kunpeng Wang, et al.
Clin Mol Hepatol. 2025;31(2):333-349.

Review

December 11, 2024


Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, et al.
Clin Mol Hepatol. 2025;31(2):350-381.

Original Article

November 29, 2024


Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clin Mol Hepatol. 2025;31(2):382-393.

Original Article

December 3, 2024


Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study
Meiyu Wu, Jing Ma, Xuehong Wang, et al.
Clin Mol Hepatol. 2025;31(2):394-408.

Original Article

December 10, 2024


GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, et al.
Clin Mol Hepatol. 2025;31(2):409-425.

Original Article

December 10, 2024


Integrated molecular characterization of sarcomatoid hepatocellular carcinoma
Rong-Qi Sun, Yu-Hang Ye, Ye Xu, et al.
Clin Mol Hepatol. 2025;31(2):426-444.

Original Article

December 23, 2024


Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation
Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, et al.
Clin Mol Hepatol. 2025;31(2):445-459.

Original Article

December 26, 2024


Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
Lung-Yi Mak, Mark Anderson, Michael Stec, et al.
Clin Mol Hepatol. 2025;31(2):460-473.

Original Article

December 30, 2024


Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
Haolong Li, Song Liu, Xu Wang, et al.
Clin Mol Hepatol. 2025;31(2):474-488.

Original Article

December 30, 2024


Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma
Weifeng Zeng, Furong Liu, Yachong Liu, et al.
Clin Mol Hepatol. 2025;31(2):489-508.

Original Article

January 2, 2025


Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, et al.
Clin Mol Hepatol. 2025;31(2):509-524.

Original Article

January 9, 2025


Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, et al.
Clin Mol Hepatol. 2025;31(2):525-547.

Original Article

January 9, 2025


Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Chang, Soung Won Jeong, et al.
Clin Mol Hepatol. 2025;31(2):548-562.

Original Article

January 13, 2025


Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma
Da-Won Kim, Jin Hyun Park, Suk Kyun Hong, et al.
Clin Mol Hepatol. 2025;31(2):563-576.


Most-cited are based on citations from 2023 ~ 2025.

Original Article
1814
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Clin Mol Hepatol. 2023;29(3):721-732.   Published online March 22, 2023
View: 25772   Download: 1,688  Web of Science: 330  Crossref: 342
Review
1748
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42.   Published online December 14, 2022
View: 20012   Download: 672  Web of Science: 276  Crossref: 305
1735
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
Clin Mol Hepatol. 2023;29(Suppl):S17-S31.   Published online November 29, 2022
View: 26018   Download: 1,474  Web of Science: 203  Crossref: 210
Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clin Mol Hepatol. 2023;29(suppl):S5-S16.   Published online December 28, 2022
View: 11865   Download: 606  Web of Science: 103  Crossref: 104
1714
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.   Published online October 13, 2022
View: 15881   Download: 802  Web of Science: 97  Crossref: 104
Special Review
1849
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi-Ae Kim, Joon Ho Moon, Won Kim
Clin Mol Hepatol. 2023;29(4):831-843.   Published online August 25, 2023
View: 6858   Download: 405  Web of Science: 63  Crossref: 78
Review
1755
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
Clin Mol Hepatol. 2023;29(2):206-216.   Published online December 22, 2022
View: 10670   Download: 535  Web of Science: 78  Crossref: 74
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
Clin Mol Hepatol. 2023;29(2):277-292.   Published online January 30, 2023
View: 10926   Download: 641  Web of Science: 70  Crossref: 71
Editorial
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clin Mol Hepatol. 2023;29(2):355-357.   Published online March 9, 2023
View: 7175   Download: 146  Web of Science: 57  Crossref: 63
Review
2010
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clin Mol Hepatol. 2025;31(Suppl):S32-S50.   Published online August 19, 2024
View: 13476   Download: 1,892  Web of Science: 52  Crossref: 54
1729
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2023;29(Suppl):S43-S57.   Published online November 22, 2022
View: 6613   Download: 206  Web of Science: 53  Crossref: 53
1842
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):1-15.   Published online July 21, 2023
View: 9869   Download: 453  Web of Science: 48  Crossref: 50
1770
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.   Published online February 1, 2023
View: 8754   Download: 480  Web of Science: 44  Crossref: 48
Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(Suppl):S79-S85.   Published online December 14, 2022
View: 6688   Download: 273  Web of Science: 41  Crossref: 45
1740
Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clin Mol Hepatol. 2023;29(Suppl):S68-S78.   Published online December 5, 2022
View: 7659   Download: 342  Web of Science: 41  Crossref: 42
1797
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(2):252-262.   Published online March 10, 2023
View: 6389   Download: 300  Web of Science: 39  Crossref: 41
1775
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):605-622.   Published online February 15, 2023
View: 7207   Download: 355  Web of Science: 38  Crossref: 40
Original Article
1760
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clin Mol Hepatol. 2023;29(2):433-452.   Published online January 4, 2023
View: 8553   Download: 273  Web of Science: 38  Crossref: 40
Review
1696
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clin Mol Hepatol. 2023;29(1):51-64.   Published online July 29, 2022
View: 7225   Download: 269  Web of Science: 36  Crossref: 37
Special Review
1854
Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(4):844-850.   Published online September 6, 2023
View: 4140   Download: 186  Web of Science: 34  Crossref: 35
Review
1691
Wnt signaling in liver regeneration, disease, and cancer
Gengyi Zou, Jae-Il Park
Clin Mol Hepatol. 2023;29(1):33-50.   Published online July 4, 2022
View: 9106   Download: 303  Web of Science: 30  Crossref: 35
Original Article
1698
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
Clin Mol Hepatol. 2023;29(1):120-134.   Published online August 12, 2022
View: 6327   Download: 243  Web of Science: 34  Crossref: 35
Review
1807
Acute-on-chronic liver failure: Terminology, mechanisms and management
Vinay Kumar BR, Shiv Kumar Sarin
Clin Mol Hepatol. 2023;29(3):670-689.   Published online March 20, 2023
View: 10074   Download: 915  Web of Science: 29  Crossref: 34
Original Article
1818
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen
Clin Mol Hepatol. 2023;29(3):705-720.   Published online May 8, 2023
View: 6813   Download: 324  Web of Science: 29  Crossref: 34
1703
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):135-145.   Published online September 5, 2022
View: 8469   Download: 400  Web of Science: 32  Crossref: 34
Review
1739
Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(Suppl):S58-S67.   Published online December 5, 2022
View: 8574   Download: 312  Web of Science: 28  Crossref: 32
1759
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.   Published online December 28, 2022
View: 8351   Download: 288  Web of Science: 25  Crossref: 31
Original Article
1881
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2024;30(2):235-246.   Published online January 26, 2024
View: 7967   Download: 320  Web of Science: 25  Crossref: 30
1838
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
Clin Mol Hepatol. 2023;29(4):987-1001.   Published online July 5, 2023
View: 6612   Download: 334  Web of Science: 27  Crossref: 30
Review
1774
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Clin Mol Hepatol. 2023;29(3):593-604.   Published online February 13, 2023
View: 6797   Download: 400  Web of Science: 32  Crossref: 30

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

  • PubMed Central
  • PubMed
  • Scopus
  • KoreaMed
  • KoMCI
  • ScienceCentral
  • DOAJ
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • Metadata
  • ORCID
  • MeSH on Demand
  • COPE
  • EMBASE
  • KOFST
  • ICMJE
  • Web of SCIENCE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2841
TOTAL : 2714288
Close layer